Patent Holder

Mark Thomas

Mark Thomas
I am a joint ‘inventor’ (one of three) on a patent for a biomarker to predict bone densitometric response to bisphosphonate drugs used in the treatment of osteoporosis. This patent was managed by UCL Biomedica (application number PCT/ GB2007/ 000941) is currently licenced to, and being developed by IP Synergy Ltd.